Analysts Set Expectations for UnitedHealth Group Inc’s FY2018 Earnings (UNH)

UnitedHealth Group Inc (NYSE:UNH) – Investment analysts at Leerink Swann upped their FY2018 earnings per share estimates for shares of UnitedHealth Group in a research report issued to clients and investors on Wednesday. Leerink Swann analyst A. Gupte now forecasts that the healthcare conglomerate will post earnings of $12.60 per share for the year, up from their prior forecast of $10.80. Leerink Swann currently has a “Outperform” rating on the stock. Leerink Swann also issued estimates for UnitedHealth Group’s FY2019 earnings at $14.40 EPS and FY2020 earnings at $16.50 EPS.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter last year, the business posted $2.11 EPS. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis.

UNH has been the topic of several other research reports. Oppenheimer raised their price objective on UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a report on Wednesday, October 18th. Cantor Fitzgerald raised their price objective on UnitedHealth Group to $225.00 and gave the company an “overweight” rating in a report on Wednesday, October 18th. Wells Fargo & Co reissued an “outperform” rating and set a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Citigroup raised their price objective on UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Piper Jaffray Companies raised their price objective on UnitedHealth Group to $242.00 and gave the company an “overweight” rating in a report on Wednesday, November 29th. Three equities research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $241.30.

Shares of UnitedHealth Group (NYSE UNH) opened at $243.35 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. UnitedHealth Group has a twelve month low of $156.49 and a twelve month high of $244.35. The firm has a market capitalization of $235,290.00, a price-to-earnings ratio of 22.72, a P/E/G ratio of 1.42 and a beta of 0.66.

In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. Insiders have sold a total of 33,655 shares of company stock worth $7,469,083 over the last ninety days. Company insiders own 0.89% of the company’s stock.

Several hedge funds have recently bought and sold shares of UNH. Covenant Asset Management LLC raised its position in shares of UnitedHealth Group by 2.7% in the 2nd quarter. Covenant Asset Management LLC now owns 7,185 shares of the healthcare conglomerate’s stock worth $1,332,000 after acquiring an additional 190 shares in the last quarter. ETF Portfolio Partners Inc. bought a new position in shares of UnitedHealth Group in the 2nd quarter worth about $206,000. Central Bank & Trust Co. raised its position in shares of UnitedHealth Group by 0.8% in the 2nd quarter. Central Bank & Trust Co. now owns 17,992 shares of the healthcare conglomerate’s stock worth $3,336,000 after acquiring an additional 134 shares in the last quarter. Johanson Financial Advisors Inc. raised its position in shares of UnitedHealth Group by 4.4% in the 2nd quarter. Johanson Financial Advisors Inc. now owns 6,802 shares of the healthcare conglomerate’s stock worth $1,264,000 after acquiring an additional 285 shares in the last quarter. Finally, Appleton Partners Inc. MA raised its position in shares of UnitedHealth Group by 1.1% in the 2nd quarter. Appleton Partners Inc. MA now owns 29,919 shares of the healthcare conglomerate’s stock worth $5,548,000 after acquiring an additional 339 shares in the last quarter. 86.09% of the stock is owned by hedge funds and other institutional investors.

WARNING: This report was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another publication, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this report can be read at https://sportsperspectives.com/2018/01/20/analysts-set-expectations-for-unitedhealth-group-incs-fy2018-earnings-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply